Krishnan Suma's Form 4 filing
Krystal Biotech, Inc. (KRYS) · filed Jan 19, 2023
- Accession no.
- 0001298711-23-000006
- Filed
- Jan 19, 2023
- Trade date
- Jan 17-18, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 10 non-derivative transactions. Open-market sales total $4.04M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Krishnan SumaCIK 0001298711 | Director, Officer (President, R&D), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 17, 2023 | Common Stock | SSaleDisposed | −20,617 | $80.70F2 | −$1,663,791.9 | 1,681,646 | Direct | Duplicate filing |
| Jan 17, 2023 | Common Stock | SSaleDisposed | −1,186 | $81.41F3 | −$96,552.26 | 1,680,460 | Direct | Duplicate filing |
| Jan 17, 2023 | Common Stock | SSaleDisposed | −345 | $82.72F4 | −$28,538.4 | 1,680,115 | Direct | Duplicate filing |
| Jan 17, 2023 | Common Stock | SSaleDisposed | −20,617 | $80.70F2 | −$1,663,791.9 | 1,743,071 | Indirect | Duplicate filing |
| Jan 17, 2023 | Common Stock | SSaleDisposed | −1,186 | $81.41F3 | −$96,552.26 | 1,741,885 | Indirect | Duplicate filing |
| Jan 17, 2023 | Common Stock | SSaleDisposed | −346 | $82.71F4 | −$28,617.66 | 1,741,539 | Indirect | Duplicate filing |
| Jan 18, 2023 | Common Stock | SSaleDisposed | −2,048 | $80.75F8 | −$165,376 | 1,678,067 | Direct | Duplicate filing |
| Jan 18, 2023 | Common Stock | SSaleDisposed | −804 | $81.56F9 | −$65,574.24 | 1,677,263 | Direct | Duplicate filing |
| Jan 18, 2023 | Common Stock | SSaleDisposed | −2,048 | $80.75F8 | −$165,376 | 1,739,491 | Indirect | Duplicate filing |
| Jan 18, 2023 | Common Stock | SSaleDisposed | −803 | $81.56F9 | −$65,492.68 | 1,738,688 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The transaction was executed in multiple trades ranging from $80.1300 to $81.1000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 2 transactions in Table I.
- F3
The transaction was executed in multiple trades ranging from $81.1300 to $82.0600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 2 transactions in Table I.
- F4
The transaction was executed in multiple trades ranging from $82.3300 to $83.2500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 2 transactions in Table I.
- F8
The transaction was executed in multiple trades ranging from $80.3500 to $81.3300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 2 transactions in Table I.
- F9
The transaction was executed in multiple trades ranging from $81.3700 to $81.9200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 2 transactions in Table I.